Glenmark Pharma gets USFDA nod for erectile dysfunction treatment

Glenmark Pharmaceuticals Ltd has received final approval from the United States Food and Drug Administration (USFDA) for Tadalafil tablets USP in the strengths of 2.5 mg, 5 mg, 10 mg and 20 mg, the company said in a regulatory filing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/383oHGe
via IFTTT

0 comments:

Post a Comment